we.love.psychedelics

The last decade has positively supported the use of psychedelics as a modern therapy for this dilemma. For example, researchers conducted studies with terminally ill patients using psychedelics to help deal with death anxiety.


Carried out by NYU and John Hopkins University, it shows that a single dose of psilocybin reduces the rate of depression and anxiety for patients awaiting terminally ill-related deaths.

The decrease of negative feelings lasted for 6 months. Up to 70% of those reported that this psilocybin trip was one of the most profound experiences of their life next to having children or experiencing the death of their parents.

Many who suffer from the negativity of deep thoughts or death anxiety create fixed narratives in their minds. These fixed narratives are the ‘voice inside our head,’ and are also emotional triggers for people.

We write off these internal dialogues as fixed truths, especially for people with depression. Fixed truths like, “I’ll never be loved,” “I don’t deserve this,” are narratives that psychedelics fight and change when we consume them.

Psychedelics weaken negative narratives, by targeting the brain’s default mode network. The default mode network or DMN is a brain network that regulates our ego, social thinking, and memories.

An overactive DMN is linked to depression, ADHD, and anxiety. When we consume magic mushrooms, the active compound psilocybin slows down the DMN.

It was all so simple at Woodstock 1969🥺! Check out our new blog at Wholecelium on Woodstock legacy! Link in the bio

#1969